These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21699747)

  • 1. Polycystic kidney disease and therapeutic approaches.
    Park EY; Woo YM; Park JH
    BMB Rep; 2011 Jun; 44(6):359-68. PubMed ID: 21699747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine models of polycystic kidney disease: molecular and therapeutic insights.
    Guay-Woodford LM
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1034-49. PubMed ID: 14600027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic kidney disease: new understanding in the pathogenesis.
    Wilson PD
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances in molecular pathogenesis and treatment of polycystic kidney disease].
    Covic M; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):11-20. PubMed ID: 18677899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic kidney disease and the renal cilium.
    Deane JA; Ricardo SD
    Nephrology (Carlton); 2007 Dec; 12(6):559-64. PubMed ID: 17995581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models for human polycystic kidney disease.
    Nagao S; Kugita M; Yoshihara D; Yamaguchi T
    Exp Anim; 2012; 61(5):477-88. PubMed ID: 23095811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular pathophysiology of cystic kidney disease: insight into future therapies.
    Avner ED; Woychik RP; Dell KM; Sweeney WE
    Int J Dev Biol; 1999; 43(5):457-61. PubMed ID: 10535324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.
    Sutters M; Germino GG
    J Lab Clin Med; 2003 Feb; 141(2):91-101. PubMed ID: 12577044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.
    Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP
    J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.
    Cowley BD
    Drugs; 2004; 64(12):1285-94. PubMed ID: 15200344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimising the management of polycystic kidney disease.
    Keenan D; Maxwell AP
    Practitioner; 2016 Feb; 260(1790):13-6, 2. PubMed ID: 27032221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.
    Bukanov NO; Smith LA; Klinger KW; Ledbetter SR; Ibraghimov-Beskrovnaya O
    Nature; 2006 Dec; 444(7121):949-52. PubMed ID: 17122773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of polycystic kidney disease.
    Calvet JP
    J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targets for polycystic kidney disease.
    Wilson PD
    Expert Opin Ther Targets; 2016; 20(1):35-45. PubMed ID: 26328773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPAR-γ agonists in polycystic kidney disease with frequent development of cardiovascular disorders.
    Nagao S; Yamaguchi T
    Curr Mol Pharmacol; 2012 Jun; 5(2):292-300. PubMed ID: 22122459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell polarity in human renal cystic disease.
    Carone FA; Nakamura S; Caputo M; Bacallao R; Nelson WJ; Kanwar YS
    Lab Invest; 1994 May; 70(5):648-55. PubMed ID: 8196361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapies for polycystic kidney disease.
    Gattone VH
    Curr Opin Pharmacol; 2005 Oct; 5(5):535-42. PubMed ID: 16085462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney.
    Sun Z; Amsterdam A; Pazour GJ; Cole DG; Miller MS; Hopkins N
    Development; 2004 Aug; 131(16):4085-93. PubMed ID: 15269167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.